These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 274738)

  • 21. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.
    Ostrand-Rosenberg S; Cohn A
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7106-10. PubMed ID: 7031669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.
    Fuji H; Iribe H
    Cancer Res; 1986 Nov; 46(11):5541-7. PubMed ID: 3489524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased proportion of CD8+ tumor responsive T cells after immunization with tum- versus tum+ rat glioma.
    Siesjö P; Visse E; Sjögren HO
    Cell Immunol; 1995 Oct; 165(2):225-33. PubMed ID: 7553887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
    Gorelik E; Peppoloni S; Overton R; Herberman RB
    Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles.
    Levine AJ; Teresky AK
    Immunogenetics; 1981; 13(5):405-12. PubMed ID: 7298085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Male-specific transplantation antigen expression by XY teratocarcinomas PCC7 and 7'.
    Johnson LL; Dove WF
    Immunogenetics; 1984; 19(3):233-41. PubMed ID: 6368378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of tumors in rats by cross-protective immunization.
    Fish DC; Bare AL; Djurickovic DB; Huebner RJ
    J Natl Cancer Inst; 1981 Nov; 67(5):1041-51. PubMed ID: 6946246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Participation of teratocarcinoma cells in mouse embryo development.
    Brinster RL
    Cancer Res; 1976 Sep; 36(9 PT 2):3412-4. PubMed ID: 788901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture.
    Artzt K; Dubois P; Bennett D; Condamine H; Babinet C; Jacob F
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2988-92. PubMed ID: 4355379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells.
    Moser AR; Johnson LL; Dove WF
    Immunogenetics; 1985; 22(6):533-41. PubMed ID: 4077147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Embryo-derived teratocarcinoma. IV. The role of immune factors in the regulation of teratocarcinogenesis.
    Damjanov I; Bagasra O; Dominis M; Solter D
    Int J Cancer; 1982 Dec; 30(6):759-62. PubMed ID: 6761280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the growth and differentiation of teratocarcinoma OC15S1 in syngeneic and allogeneic mice].
    Dyban PA
    Biull Eksp Biol Med; 1984 Jan; 97(1):71-2. PubMed ID: 6692027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
    LeGrue SJ; Simcik WJ; Frost P
    Cancer Res; 1987 Aug; 47(16):4413-6. PubMed ID: 3607772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
    Flood PM; Schreiber H; Ron Y
    J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coombs-positive reactions in mice during transplantation of syngeneic tumors].
    Buntsevich AM; Mikheeva NV
    Biull Eksp Biol Med; 1983 May; 95(5):81-4. PubMed ID: 6850095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the immune response to teratocarcinoma in mice sensitized by sperm antigens.
    Teodorczyk-Injeyan JA; Jewett MA; Falk RE
    J Reprod Immunol; 1982 May; 4(2):67-78. PubMed ID: 7108858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryo-derived teratocarcinoma: I. The role of strain and gender in the control of teratocarcinogenesis.
    Solter D; Dominis M; Damjanov I
    Int J Cancer; 1979 Dec; 24(6):770-2. PubMed ID: 544530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.